Court of Appeal Confirms ‘Actual’ v ‘Notional’ Use Distinction
In 2020 NZCA 306 Pharmazen Limited v Anagenix IP Limited the Court of Appeal confirmed that the likelihood of actual use is not relevant to discharging the onus of establishing lack of deception or confusion on a notional use basis.
Manufacturer’s Intention Not Necessarily Relevant to Infringement of Swiss-Style Claims
In Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd the unanimous decision of the Full Court of the Federal Court (FCAFC) held that when assessing whether a Swiss-style patent claim has been infringed the intention of the accused infringer is not a necessary factor to take into consideration...
Indemnity Replaces Up-Front Security for Customs Border Protection Notices
With effect from 1st June 2020 Customs no longer require up-front security from trade mark and copyright owners when requesting Customs to detain goods suspected of being pirated or counterfeit.
Innovative Prescription Medicines Accepted for Evaluation to be Published Earlier
Following the Therapeutic Goods Administration’s (TGA) February 2019 consultation on whether to publish that a prescription medicine is under evaluation they have now released an implementation options paper with the objective of increasing public transparency around whether treatment options are likely to be available...